Interventional Clinical Trial in Patients in Overactive Bladder With Nocturia in Women
Status:
Completed
Trial end date:
2014-11-01
Target enrollment:
Participant gender:
Summary
The purpose of the trial is to investigate the efficacy of combining tolterodine and
desmopressin compared with tolterodine monotherapy in the treatment of women with overactive
bladder with nocturia in terms of reduction of nocturnal voids during 3 months of treatment